SEC Filing Summary: Thumzup Media Corporation (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Thumzup Media Corporation (Ticker: TZUP) on October 9, 2025, reporting events occurring on October 4, 2025. The filing addresses a change in corporate governance and a subsequent notification of non-compliance with Nasdaq listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
- Board Resignation: Robert Haag resigned from the Board of Directors and all committee memberships (Audit, Compensation, and Nominating and Corporate Governance) effective October 4, 2025.
- Reason for Departure: The resignation was not the result of any disagreement with the Company regarding operations, policies, practices, management, or the Board.
- Listing Non-Compliance: The resignation resulted in the Audit Committee falling below the required three independent members, violating Nasdaq Listing Rule 5605(c). The Company notified Nasdaq of this non-compliance on October 8, 2025, and received formal notification on October 9, 2025.
Outlook, Risks, and Management Commentary
The Company is currently in a cure period to regain compliance with Nasdaq Listing Rule 5605(c)(4). This period will expire at the earlier of the next annual meeting of stockholders or October 5, 2026. Management intends to appoint an additional independent director to the Audit Committee prior to the expiration of this cure period to resolve the listing deficiency.
Investor Verification Checklist
- Verify the current composition of the Audit Committee to confirm the number of independent directors.
- Monitor announcements regarding the appointment of a new independent director to satisfy Nasdaq Rule 5605(c).
- Review the Company's timeline for its next annual meeting of stockholders to determine the exact expiration date of the cure period.
- Confirm that no other undisclosed disagreements exist regarding the resignation of Robert Haag.